Assignee
APOLLOMICS INC
US·3 granted patents·4 pending applications·2 citations·filing 2019–2022
Top patents by PatentIndex Score
7 records- 0183US11560429B2Anti PD-1 antibodiesAPOLLOMICS INC·Filed 2021·Granted Jan 24, 2023·1 cites·13 claims
- 0277US10981994B2Anti PD-1 antibodiesAPOLLOMICS INC·Filed 2019·Granted Apr 20, 2021·1 cites·24 claims
- 0369US11827707B2Anti PD-L1 antibodiesAPOLLOMICS INC·Filed 2021·Granted Nov 28, 2023·0 cites·25 claims
- 0456US2024218453A1Diagnostic and treatment of cancer using c-met inhibitorAPOLLOMICS INC·Filed 2022·Application pending·0 cites
- 0548US2023338294A1Novel pharmaceutical formulation for c-met inhibitorAPOLLOMICS INC·Filed 2021·Application pending·0 cites
- 0645US2022348674A1Novel anti-cd40 antibodiesAPOLLOMICS INC·Filed 2021·Application pending·0 cites
- 0740US2020405719A1Cancer treatment using combination of neutrophil modulator with modulator of immune checkpointAPOLLOMICS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →